JUN 12, 2017 05:41 PM PDT

Designer Molecule can Stop the Flu

WRITTEN BY: Carmen Leitch

Scientists are taking a new approach in the fight against the flu. They have engineered a protein that acts to stop the virus from infecting cells, and while a lot more research is yet to be done, the new protein has been promising in tests done with cells in culture and animal models. The work, outlined in the video below, has been published in Nature Biotechnology.

Influenza is a public health threat, causing serious illness in anywhere from three to five million people in one year, an infection that is deadly to some 250,000 to 500,000 people, usually those with weak immune systems. 

Vaccines are one way people can help prevent flu infection, but they are not effective against all strains and they sometimes don’t trigger enough of a response in some recipients. Drugs that act to fight the flu have traditionally been directed at proteins in the viral coat. Neuraminidase is one, but viruses have already started to build resistance to neuraminidase drugs. Another target on scientists’ radar is hemagglutinin (HA). 

HA, a protein shaped like a mushroom, functions to aid the cell infection process. It begins by attaching its cap to three sugar molecules on the targeted cell individually. After binding, HA uses its stem like a hook to pull the virus close to the cell, after which it fuses and ejects the viral load into the cell.

A designer protein (brown and orange) fits snugly on top of the influenza virus's hemagglutinin protein (green), which helps the virus latch onto and infect cells. / Credit: Eva-Maria Strauch

David Baker, a computational biologist at the University of Washington in Seattle, led researchers in 2011 who synthesized a protein that binds to the stem portion of HA and could halt viral infection in cell culture models. The stem is often shielded by protein that puts it out the reach of drugs, however.

Baker’s team has now engineered proteins that target the exposed cap of HA instead.

The investigators tested copies of the protein that had been team immobilized nitrocellulose, a membrane that is like a kind of paper. After exposing it to various viral strains, it showed that it could attach to the virus without releasing it. “We call it flu glue, because it doesn’t let go,” Baker explained.

After trying out the protein in culture, the protein could prevent infection in the cells. It also stopped illness in mice when provided one day before or after exposure to virus.

The scientists note that this new protein is unlikely to become a medicine. One issue, explained Baker, is that the protein will not attach to flu strains that tend to sicken people. As such, any future drug be made up of a cocktail of proteins that attach to the HA cap or ones which act together with proteins that bind to the stem. Additionally, designer proteins have to be properly evaluated for safety, Crowe said; they are quite different from natural antibodies that halt HA. “The further you get away from a natural antibody, the less you can predict what will happen,” Crowe said.

This designer protein could one day be used in cheap diagnostic tests for the flu, like a pregnancy test, Baker said. It could also help doctors select the best medicine for flu treatment.

 

Sources: Science, Nature Biotechnology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 23, 2019
Cell & Molecular Biology
OCT 23, 2019
How the Kava Plant Creates Medicinal Compounds
Nature has given us some of our best medicines; it's thought that as many as half the drugs we used are derived from natural products....
OCT 23, 2019
Genetics & Genomics
OCT 23, 2019
A 3D Look at the Genome Reveals a Super Enhancer
We can write out the sequence of the genome, but the three-dimensional structure of the molecule is important to its function as well....
OCT 23, 2019
Neuroscience
OCT 23, 2019
Why are Some Memories Stronger than Others?
Why is that you remember the name of your childhood best friend, but you struggle to recall the name of the person you just met- even if they told you it j...
OCT 23, 2019
Immunology
OCT 23, 2019
Treating Alzheimer's? Target Microglia
The body’s own immune cells may be the common denominator in Alzheimer’s disease. In a new study of the relationship between microglia, tau pro...
OCT 23, 2019
Cell & Molecular Biology
OCT 23, 2019
Discovery of Cell's Mechanism for Sensing Oxygen Wins Nobel
It may be possible to attack cancer or treat anemia or other diseases by interfering with the cells' ability to sense oxygen....
OCT 23, 2019
Cell & Molecular Biology
OCT 23, 2019
Irritable Bowel Syndrome Gut Pain is Traced Back to Itch Receptors
Researchers have IDed nervous system receptors that can activate neurons and cause a painful feeling of itchy gut, often described by IBS patients....
Loading Comments...